[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 2075 Introduced in Senate (IS)]

<DOC>






119th CONGRESS
  1st Session
                                S. 2075

 To authorize the Secretary of the Army to accelerate development and 
     procurement of aeromedical evacuation and special operations 
configurations of the Future Long Range Assault Aircraft, and for other 
                               purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             June 12, 2025

   Mr. Cruz introduced the following bill; which was read twice and 
              referred to the Committee on Armed Services

_______________________________________________________________________

                                 A BILL


 
 To authorize the Secretary of the Army to accelerate development and 
     procurement of aeromedical evacuation and special operations 
configurations of the Future Long Range Assault Aircraft, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Future Long Range Assault Aircraft 
Medical Evacuation and Special Operations Procurement Act of 2025''.

SEC. 2. AUTHORIZATION FOR DEVELOPMENT AND PROCUREMENT OF AEROMEDICAL 
              EVACUATION AND SPECIAL OPERATIONS CONFIGURATIONS OF THE 
              FUTURE LONG RANGE ASSAULT AIRCRAFT.

    (a) Authority To Develop and Procure.--The Secretary of the Army 
may accelerate the research, development, test, evaluation, and initial 
procurement of variant configurations of the Future Long Range Assault 
Aircraft (FLRAA), specifically--
            (1) a medical evacuation (MEDEVAC) configuration designed 
        to enhance patient care capabilities and survivability, 
        including advanced telemedicine integration, expanded patient 
        capacity, and increased operational reach; and
            (2) a special operations configuration tailored to the 
        needs of the United States Special Operations Command 
        (USSOCOM), including integration of advanced sensors, weapons 
        systems, launched effects, and plug-and-play mission modules.
    (b) Program Objectives.--In exercising authority under subsection 
(a), the Secretary shall ensure that--
            (1) the medical evacuation and the special operations 
        variants are developed under subsection (a) in coordination 
        with relevant stakeholders, including the Army Medical 
        Department and United States Special Operations Command;
            (2) the development timeline to carry out subsection (a) is 
        aligned to enable rapid prototyping, user evaluation, and risk 
        reduction prior to full-rate production; and
            (3) commonality in components and systems is pursued across 
        configurations of the Future Long Range Assault Aircraft to the 
        maximum extent practicable to reduce long-term acquisition and 
        sustainment costs.
    (c) Limitation on Use of Funds.--No additional appropriations are 
authorized under this section. Development and procurement authorized 
under this section shall be subject to the availability of 
appropriations provided in advance in appropriations Acts.
    (d) Report to Congress.--Not later than 180 days after the date of 
the enactment of this Act, the Secretary of the Army shall submit to 
the congressional defense committees a report detailing--
            (1) the status of development and testing of the medical 
        evacuation and special operations variants of the Future Long 
        Range Assault Aircraft;
            (2) estimated timelines for milestone decisions, 
        operational testing, and fielding for research, development, 
        test, evaluation, and initial procurement under subsection (a); 
        and
            (3) anticipated funding needs in future fiscal years for 
        full development and procurement of the variants described in 
        paragraph (1).
                                 <all>